IDS Photo Cropped_0025_IDS 9 017

Available now: Annual Report and Accounts 2016

Immunodiagnostic Systems Holdings PLC are pleased to announce the release of the Annual Report and Accounts for the 2016 financial year. This report and the Annual General Meeting documents are now available for download from the following links: Annual Report and Accounts 2016 Notice of Annual General Meeting 2016


IDS and NattoPharma invite you to attend our lunchtime symposium

Date & time: Sunday 22nd May 2016, 13:30 – 15:00 Lunch boxes will be served from 13:30 Location: Hall N, Austria Center Vienna, Vienna, Austria The Infernal Triad: Matrix Gla-Protein, Vitamin K and Vascular Calcification Vascular mineralisation is currently recognised as an actively regulated process where it was previously regarded as a passive end-stage process. […]



15/03/2016 Join us at the 2016 Focus (19th – 21st April, Warwick, UK). IDS is expanding its automated and manual immunoassay solutions for the calcium, growth, bone, hypertension, fertility*, autoimmunity and infectious disease areas. IDS-iSYS immunoassay system – optimizes specialty testing in your laboratory without compromising quality Fully on-board IDS-iSYS reagents – simplifies laboratory workflow […]

Immunodiagnostic Systems Holdings plc Board Appointment

Immunodiagnostic Systems Holdings plc (“IDS” or “the Company” or “the Group”), a leading solution provider to the clinical laboratory diagnostic market, is pleased to announce that Klaus Peter Kaspar, aged 63, will join the Board of IDS as a NonExecutive Director with effect  from 1  November  2015. Peter has over 35 years’ of experience in life sciences and diagnostics. From 2005 […]